Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,973.00
Bid: 1,971.00
Ask: 1,972.00
Change: 17.00 (0.87%)
Spread: 1.00 (0.051%)
Open: 1,963.00
High: 1,994.00
Low: 1,959.00
Prev. Close: 1,956.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks Firm Before UK Budget And US Fed Decision

Wed, 16th Mar 2016 12:03

LONDON (Alliance News) - London saw a steady morning of equities trading Wednesday, as investors held back ahead of the UK budget and the US Federal Reserve's monetary policy decision and press conference in the afternoon and evening.

In the meantime, there was a UK jobs report for investors to chew on. The UK unemployment rate remained unchanged at a 10-year low during November to January period, data from the Office for National Statistics showed.

The jobless rate came in at 5.1% in three months to January, unchanged from the fourth quarter of 2015 and in-line with economists' expectations. The employment rate was 74.1%, the joint highest since comparable records began in 1971.

Average weekly earnings for employees increased by 2.1% including bonuses, and by 2.2% excluding bonuses, compared with a year earlier. Economists had forecast earnings including bonus to rise 2.0%.

Lloyds Bank said even though wages came higher than expected, they remain weak overall. "The combination of job gains alongside weak wage growth remains a puzzle for policymakers," it said.

Lloyds said the Bank of England explained that weaker wages could be due to a combination of low headline inflation and compositional effects, reflecting the skew of job growth towards relatively lower-skilled and lower-paid workers.

"Even if the influence of both factors unwind over time, the low rates of pay growth seem likely to persist well into 2016. As such, pay pressures provide little urgency for a tighter policy stance," Lloyds said.

Investec economist Chris Hare somewhat disagrees, saying there is evidence that the weakness in wage growth is unwinding and, in the coming months, will move closer towards its circa 4% pre-recession average rate.

The pound dropped slightly against the dollar following the employment report. At midday, sterling was quoted at USD1.4096, lower than USD1.4159 seen at the London stock market close on Tuesday.

London stocks were unmoved by the jobs data. At midday, the FTSE 100 was up 0.1%, or 6.71 points, to 6,146.68.

The FTSE 250 was up 0.2% at 16,663.99 and the AIM All-Share up 0.1% at 711.50.

The next focus for the London market will be the UK Budget, which is scheduled to get underway at 1230 GMT. Chancellor of the Exchequer George Osborne is set to take aim at public services, with spending cuts set against splashy new spending commitments for roads, railways and housing, plus incentives to increase the amount Britons save.

Osborne is expected to make around GBP4.0 billion in further cuts to public services in the UK, with an already stated intention to trim around 50 pence from every GBP100.00 that Westminster spends by 2020, by which time Osborne has an eye on the UK government turning to a surplus.

"As much as he will be conscious that he can’t afford to waste the budgets left between now and his own self-imposed 2020 deadline to be running a surplus, he will not want to do anything that might jeopardise the looming Brexit vote," said Alastair McCaig, market analyst at IG.

In Europe, the French CAC 40 was down 0.1% and the German DAX 30 was up 0.4%. US futures pointed the DJIA and Nasdaq 100 both flat and the S&P 500 down 0.1%.

Investors also await the statement from the Federal Open Market Committee at 1800 GMT revealing its monetary policy decision and economic projections. Fed Chair Janet Yellen will hold a press conference afterward at 1830 GMT.

The US central bank is widely expected to make no changes to its target for the Federal Funds rate, but is likely to hint at further rate hikes later in 2016.

In UK corporate news, London Stock Exchange Group and Deutsche Boerse said they have reached an agreement to merge, having disclosed they were holding talks last month.

Xavier Rolet, the chief executive of LSE who will stand down when the deal is completed, said he was "very pleased" to finally announce the proposed merger between the two firms, and said he "100% supports the merger" and believes it is "absolutely the right time" to conduct the deal.

The merger will be carried out through the creation of a new UK holding company which will acquire LSE Group via a scheme of arrangement. LSE Group shareholders will get 0.4421 of a share in the newly-combined company for each LSE share they currently own, meaning they will own 45.6% of the group, with Deutsche Boerse shareholders have 54.4%.

The pair said the combined group will maintain headquarters in London and Frankfurt, and the board will have equal representation from both companies. LSE traded down 0.3%.

Hikma Pharmaceuticals reported a fall in pretax profit in 2015, but forecast a significant rise in revenue for the year ahead, helped by its recent acquisition of the Roxane Laboratories Inc, despite lowering its guidance for the Roxane business last month.

The company reported a pretax profit of USD318 million, down from USD362 million in 2014, as revenue slipped to USD1.44 billion from USD1.49 billion the year before. Analysts had expected Hikma to report a pretax profit of USD302.2 million on revenue of USD1.44 billion, so it beat expectations for profit and met them for revenue.

The company was down 1.3%, making it one of the worst performers in the FTSE 100. The stock will fall out of the blue-chip index into the FTSE 250 from the start of trade Monday as a result of the latest FTSE index review.

Engineer Smiths Group said its pretax profit grew in the first half thanks to better operating margins, but its underlying results weakened amid continued pressure on its John Crane energy services business.

The diversified engineer, which also will be demoted from the FTSE 100 next week, said pretax profit for the six months to the end of July was GBP168.0 million, up from GBP131.0 million a year earlier. On a headline basis, which strips out exceptional items, pretax profit fell to GBP189.0 million from GBP208.0 million.

John Crane, which provides engineering services to energy clients, saw revenue fall due to challenging oil and gas markets, though its aftermarket services sales remained relatively resilient. Aftermarket revenue fell 7.0%, while first-fit customer sales declined by 15%. The order book for John Crane also weakened, though not by the same rate as the first half sales decline, Smiths said.

Smiths Group traded down 1.6%.

Tullow Oil was the best performer in the FTSE 250, up 4.1%. The oil and gas company said it has encountered "good oil shows" across an interval of over 700 metres in the Cheptuket-1 well in Block12A in northern Kenya. The well is the first one to test the Kerio Valley Basin and was drilled by the PR Marriott Rig-46 to a final depth of 3,083 metres.

Moneysupermarket.com Group was down 3.3%. The price comparison site's founder Simon Nixon has completed the sale of his entire remaining stake in the company, according to sole bookrunner Credit Suisse.

Credit Suisse Securities placed 37.8 million shares on behalf of Nixon at 328.00 pence per share, raising a total of GBP124.0 million. The shares sold represent around 6.9% of the company's issued share capital.

Moneysupermarket shares closed at 343.6p on Tuesday and were quoted at 332.20p Wednesday. The intended sale was announced soon after the market close Tuesday.

Cloud-based video technology group Forbidden Technologies said it has signed a deal with US technology giant Microsoft Corp for it Forscene cloud video platform.

Under the deal, Microsoft will be able to sell the Forscene platform through its Azure cloud computing marketplace.

"Not only is this agreement a further validation of the efficacy of our technology, it's an important milestone as we further expand our sales apparatus. Whilst we expect to generate some income directly from this agreement in 2016, we anticipate its financial impact being most acutely seen from 2017," said Aziz Musa, Forbidden's chief executive.

The company was the best performer in the AIM All-Share index, up 27%.

Aside from the UK budget and Fed, still ahead in the economic calendar, the US consumer price index and US industrial production are both due at 1230 GMT, while the Energy Information Administration's crude oil stocks are at 1430 GMT.

By Neil Thakrar; neilthakrar@alliancenews.com; @NeilThakrar1

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
24 May 2022 07:09

Hikma's Siggi Olafsson stands down as CEO

(Sharecast News) - Drugmaker Hikma Pharmaceuticals revealed on Tuesday that chief executive Siggi Olafsson has resigned from both the role and the company's board of directors in order to pursue other opportunities.

Read more
13 May 2022 16:01

UK shareholder meetings calendar - next 7 days

Monday 16 May 
88 Energy LtdAGM
Allianz Technology Trust PLCAGM
Blackbird PLCAGM
BSF Enterprise PLCGM
Crossword Cybersecurity PLCAGM
DigitalBox PLCAGM
Ethernity Networks LtdAGM
Jubilee Metals Group PLCGM - re right of directors to allot equity securities for cash
Mast Energy Developments PLCAGM
Metal Tiger PLCAGM
Tuesday 17 May 
Accesso Technology Group PLCAGM
Capital & Regional PLCAGM
Chaarat Gold Holdings LtdAGM
Chesnara PLCAGM
Equals Group PLCAGM
European Assets Trust PLCAGM
Fidelity Japan Trust PLCAGM
Fintel PLCAGM
Fresnillo PLCAGM
GCP Asset Backed Income Fund LtdAGM
GENinCode PLCFull Year Results
Greggs PLCAGM
IQGeo Group PLCAGM
Kefi Gold & Copper PLCGM re share placing
Mears Group PLCAGM
Mercantile Investment Trust PLCAGM
Vitec Group PLCAGM
Vivo Energy PLCAGM
Wednesday 18 May  
ABCAM PLCAGM
abrdn PLCAGM in Edinburgh
Alliance Pharma PLCAGM
Burford Capital LtdAGM
Coats Group PLCAGM
CVC Credit Partners European Opportunities LtdAGM
EKF Diagnostics Holdings PLCAGM
Highcroft Investments PLCAGM
Impax Environmental Markets PLCAGM
JPMorgan American Investment Trust PLCAGM
Keller Group PLCAGM
LMS Capital PLCAGM
Merchants Trust PLCAGM
PensionBee Group PLCAGM
Permanent TSB Group Holdings PLCAGM
PYX Resources LtdAGM
Riverstone Credit Opportunities Income PLCAGM
Schroder UK Public Private Trust PLCAGM
Science Group PLCAGM
Seplat Energy PLCAGM
TI Fluid Systems PLCAGM
Vesuvius PLCAGM
Thursday 19 May  
Bigblu Broadband PLCAGM
Brand Architekts Group PLCGM re takeover of InnovaDerma
Capital & Regional PLCAGM
Computacenter PLCAGM
Cornish Metals IncGM re equity raise
Dialight PLCAGM
Ebiquity PLCAGM
Eqtec PLCAGM
Essentra PLCAGM
Fevertree Drinks PLCAGM
Gamma Communications PLCAGM
Genuit Group PLCAGM
Headlam Group PLCAGM
Inchcape PLCAGM
InnovaDerma PLCGM re takeover by Brand Architekts
Irish Residential Properties REIT PLCAGM
K3 Business Technology Group PLCAGM
Light Science Tech Holdings PLCAGM
Live Co Group PLCGM
McColl's Retail Group PLCAGM
musicMagpie PLCAGM
Network International Holdings PLCAGM
Next PLCAGM
Pharos Energy PLCAGM
Property Franchise Group PLCAGM
Rotala PLCAGM
Smart Metering Systems PLCAGM
St James's Place PLCAGM
Tyman PLCAGM
Friday 20 May  
Bank of Cyprus Holdings PLCAGM
Croda International PLCAGM
Deliveroo PLCAGM
Georgia Capital PLCAGM
Hikma Pharmaceuticals PLCEGM re capital reduction
Keywords Studios PLCAGM
Real Estate Investors PLCAGM
Reckitt Benckiser Group PLCAGM
Resolute Mining LtdAGM
Restore PLCAGM
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
6 May 2022 09:47

LONDON BROKER RATINGS: Downgrades for Centrica and Rathbones

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
5 May 2022 12:11

LONDON MARKET MIDDAY: Pound slips as BoE opts for quarter-point hike

(Alliance News) - Stock prices in London were higher, while the pound was flat, on Thursday, after the Bank of England as expected raised UK interest rates by a quarter percentage point.

Read more
5 May 2022 10:51

Signs of slowdown on the continent

Welcome to the home for real-time coverage of markets brought to you by Reuters reporters. You can share your thoughts with us at markets.research@thomsonreuters.com

SIGNS OF SLOWDOWN ON THE CONTINENT (1051 GMT)

Read more
5 May 2022 09:24

TOP NEWS: Hikma shares fall 10% on delay to Jazz Pharmaceuticals drug

(Alliance News) - Shares in Hikma Pharmaceuticals PLC fell early Thursday, after the drugmaker downgraded guidance for its Generics business due to the delayed launch of a generic of the Xyrem treatment for narcolepsy.

Read more
5 May 2022 08:58

LONDON MARKET OPEN: Mondi and Shell lift FTSE 100 after strong updates

(Alliance News) - Stock prices in London opened sharply higher on Thursday after the US Federal reserve assuaged fears over further aggressive monetary policy tightening, while positive updates from Mondi and Shell boosted the FTSE 100.

Read more
5 May 2022 08:02

Hikma cuts 2022 generics guidance due to drug launch delay

(Sharecast News) - Hikma Pharmaceuticals cut guidance for its generics business on Thursday, citing a delay to a drug launch.

Read more
29 Apr 2022 17:44

IN BRIEF: Hikma says has not entered license agreement with Opiant

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Confirms that it has not entered into any transaction with Opiant Pharmaceutical UK, following a PR Newswire announcement issued on Friday. The release said Opiant and Hikma entered into a commercialisation and license agreement for OPNT003, Nasal Nalmefene, in Europe and the UK.

Read more
29 Apr 2022 17:01

LONDON MARKET CLOSE: Stocks end volatile April on high note

(Alliance News) - Stocks in London on Friday ended a volatile month of April in a positive fashion, amid a continued rush of company earnings, while markets in the US sank as high-profile tech names disappointed.

Read more
29 Apr 2022 09:09

Hikma Pharmaceuticals notes "slow" start for Generics business in 2022

(Alliance News) - Hikma Pharmaceuticals PLC said on Friday that both its Injectables and Branded businesses have performed well at the start of the year but noted its Generics business has experienced some headwinds.

Read more
29 Apr 2022 08:32

Hikma shares fall as generics unit faces headwinds

(Sharecast News) - Hikma Pharmaceuticals shares fell as the company reported headwinds at its generics business.

Read more
29 Apr 2022 08:25

LONDON BRIEFING: Pearson has positive first quarter, buys language app

(Alliance News) - Educational materials publisher Pearson on Friday provided a positive update on first quarter trading, while also announcing a new acquisition.

Read more
21 Apr 2022 16:06

UK dividends calendar - next 7 days

Friday 22 April 
JPMorgan Global Emerging Markets Income Trust PLCdividend payment date
Henderson Eurotrust PLCdividend payment date
Monday 25 April 
abrdn Smaller Cos Income Trust PLCdividend payment date
Tuesday 26 April 
Anglo American PLCdividend payment date
Anglo American PLCspecial dividend payment date
Invesco Asia Trust PLCdividend payment date
Wednesday 27 April 
Close Brothers Group PLCdividend payment date
Thursday 28 April 
4imprint Group PLCex-dividend date
AEW UK REIT PLCex-dividend date
AVI Japan Opportunity Trust PLCex-dividend date
Bakkavor Group PLCex-dividend date
Carr's Group PLCex-dividend date
Coats Group PLCex-dividend date
CQS Natural Resources Growth & Income PLCex-dividend date
CQS New City High Yield Fund Ltdex-dividend date
Derwent London PLCex-dividend date
Drax Group PLCex-dividend date
Ecofin Global Utilities & Infrastructure Trust PLCex-dividend date
Fresnillo PLCex-dividend date
Henderson Far East Income Trust PLCex-dividend date
Hikma Pharmaceuticals PLCdividend payment date
HSBC Holdings PLCdividend payment date
Kenmare Resourcesex-dividend date
LSL Property Services PLCex-dividend date
M&G PLCdividend payment date
M P Evans Group PLCex-dividend date
Mobius Investment Trust PLCex-dividend date
Morgan Advanced Materials PLCex-dividend date
Morgan Sindall Group PLCex-dividend date
Mortgage Advice Bureau (Holdings) PLCex-dividend date
Northamber plcdividend payment date
Porvair PLCex-dividend date
Reckitt Benckiser Group PLCex-dividend date
Rightmove PLCex-dividend date
Sabre Insurance Group PLCex-dividend date
Sabre Insurance Group PLCspecial ex-dividend date
Schroder Oriental Income Fund Ltdex-dividend date
Secure Income REIT PLCex-dividend date
Smart Metering Systems PLCdividend payment date
St James's Place PLCex-dividend date
Synthomer PLCex-dividend date
Tate & Lyle PLCspecial ex-dividend date
TT Electronics PLCex-dividend date
Tyman PLCex-dividend date
XP Power Ltddividend payment date
  
Copyright 2022 Alliance News Limited. All Rights Reserved.

Read more
21 Apr 2022 14:37

IN BRIEF: Hikma Pharmaceuticals completes Custopharm deal

Hikma Pharmaceuticals PLC - London-based generic drugmaker - Completes acquisition of Custopharm Inc from Water Street Healthcare Partners, following approval from the US Federal Trade Commission. Back in September, Hikma agreed to buy the California-based generic injectable products company for a total of up to USD425 million. Deal will add up to 13 approved products and additional pipeline products.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.